+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Foot and Mouth Disease Vaccines Market - Growth, Trends, and Forecast (2020 - 2025)

  • PDF Icon

    Report

  • 120 Pages
  • February 2020
  • Region: Global
  • Mordor Intelligence
  • ID: 4987145
The prevention and treatment of deadly animal diseases are key market indicators for the vaccine market. Certain factors such as increasing incidences of zoonotic diseases, increasing demand for animal product and rising R&D activities in animal healthcare causes foot and mouth-related diseases which boost the demand for their vaccines in the market. The zoonotic diseases are naturally transmitted from animals to humans. Adverse climatic transformations, and rapid globalization are the major factors increasing the cases of zoonotic diseases over the past decades. Zoonotic diseases are quite common around the world. According to the scientists of Centers for Disease Control and Prevention (CDC), over 6 out of every 10 known infectious diseases in humans are spread via animals, moreover, 3 out of every 4 new or emerging infectious diseases are spread from animals. So, it is evident that these diseases are major public health problem worldwide. Thus, increasing burden of zoonotic diseases is expected to impact the growth of the market.

Key Market Trends

Cattle Segment is Expected to Show Better Growth Over the Forecast Period

Based on Animal Type, it is segmented into cattle, sheep and goat, pig and others. The growth of the cattle segment is mainly attributed to the high population of cattle across the world and the dominance of cattle farming as a major income source for people in many countries. For example, in countries such as China and Mexico where the livestock population is high, the chances of getting an infection would be higher. According to the Food and Agriculture Organization (FAO), the worldwide population of cattle is more than 1.4 billion, out of which a large proportion is noted in countries such as India, Brazil, and China. The awareness about cattle diseases and zoonosis is currently growing due to the high demand for improved and healthy meat. Hence, these factors are anticipated to have positive impact on the market in the coming years.

North America is Expected to Dominate the Foot and Mouth Disease Vaccines Market

North America region is among the major contributor to the foot and mouth disease vaccines market, owing to the implementation of animal healthcare benefits across the region. The market is growing rapidly due to the presence of advanced animal healthcare programs coupled with awareness regarding animal health is projected to drive the regional market growth. According to 2017 data by the North American Meat Institute, the poultry and meat industries are the largest division of the United States agriculture sector. Moreover, rising disease burden in animals is further pushing the need for effective and quick treatment options which is expected to propel the growth of the market, over the forecast period.

Competitive Landscape

The global players in the foot and mouth disease vaccines market are – Biogénesis Bagó, Boehringer Ingelheim GmbH, Brilliant Bio Pharma Pvt Ltd, China Animal Husbandry Group, Indian Immunologicals Limited, Limor de Colombia, Merck & Co. Inc., VECOL S.A and VETAL Animal Health Products.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client's requirements.
  • 3 months of analyst support.


This product will be delivered within 2 business days.

Table of Contents

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Zoonotic Diseases
4.2.2 Increasing Demand for Animal Product
4.2.3 Rising R&D Activities in Animal Healthcare
4.3 Market Restraints
4.3.1 High Storage Costs for Vaccines
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Conventional Vaccines
5.1.2 Emergency Vaccines
5.2 By Animal Type
5.2.1 Cattle
5.2.2 Sheep and goat
5.2.3 Pig
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Biogenesis Bago
6.1.2 Boehringer Ingelheim GmbH
6.1.3 Brilliant Bio Pharma Pvt Ltd
6.1.4 China Animal Husbandry Group
6.1.5 Indian Immunologicals Limited
6.1.6 Limor de Colombia
6.1.7 Merck & Co. Inc.
6.1.8 VECOL S.A
6.1.9 VETAL Animal Health Products
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Biogenesis Bago
  • Boehringer Ingelheim GmbH
  • Brilliant Bio Pharma Pvt Ltd
  • China Animal Husbandry Group
  • Indian Immunologicals Limited
  • Limor de Colombia
  • Merck & Co. Inc.
  • VECOL S.A
  • VETAL Animal Health Products

Methodology

Loading
LOADING...